Suchergebnisse - (Person:"Rengo, Giuseppe")

PubPharm (8)

1

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management : Might GRK2 Serve as a New Biomarker?

enthalten in: Cells | 2021

von Bencivenga, L. | Palaia, M. | Sepe, I. | +5

2

Predisposing factors to heart failure in diabetic nephropathy : a look at the sympathetic nervous system hyperactivity

enthalten in: Aging clinical and experimental research | 2019

von Komici, K. | Femminella, G. | de Lucia, C. | +6

3

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2

enthalten in: Frontiers in pharmacology | 2019

von Cannavo, A. | Marzano, F. | Elia, A. | +10

4

Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity

enthalten in: Aging clinical and experimental research | 2018

von Komici, K. | Femminella, G. | de Lucia, C. | +6

5

GRK2 as a therapeutic target for heart failure

enthalten in: Expert opinion on therapeutic targets | 2018

von Cannavo, A. | Komici, K. | Bencivenga, L. | +5

6

Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure

enthalten in: European journal of clinical investigation | 2015

von Rengo, G. | Pagano, G. | Paolillo, S. | +12

7

The adrenergic system in cardiovascular pathophysiology : a translational science point of view

enthalten in: Frontiers in physiology | 2014

von Rengo, G.

8

Adrenal adrenoceptors in heart failure

enthalten in: Frontiers in physiology | 2014

von de Lucia, C. | Femminella, G. | Gambino, G. | +7

1
[1]